Workflow
向特定对象发行股票
icon
Search documents
兴齐眼药: 关于2025年度向特定对象发行股票摊薄即期回报的风险提示及填补回报措施和相关主体承诺的公告
Zheng Quan Zhi Xing· 2025-05-27 11:24
Core Viewpoint - The company plans to issue shares to specific investors in 2025, raising up to 850 million yuan, which may dilute immediate returns for existing shareholders [2][3][8]. Group 1: Financial Impact of Share Issuance - The total number of shares before the issuance is 245,348,945, and the maximum number of shares to be issued is 73,604,683, which represents up to 30% of the pre-issuance total [2][3][6]. - The projected net profit for 2025, assuming no growth, is estimated to remain at 347,542,460 yuan, leading to a basic earnings per share (EPS) of 1.38 yuan post-issuance [6][7]. - Under three scenarios of net profit growth (0%, 10%, and 20%), the diluted EPS and return on equity (ROE) will decrease post-issuance, indicating a potential dilution of shareholder returns [6][7][8]. Group 2: Necessity and Reasonableness of the Issuance - The funds raised will be allocated to the construction of a research and development center and to supplement working capital, aligning with the company's strategic direction and industry trends [9][10]. - The issuance is deemed necessary to enhance the company's R&D capabilities and improve its financial structure, which is expected to strengthen its competitive position in the market [9][10][11]. Group 3: Measures to Mitigate Dilution of Returns - The company plans to implement measures to counteract the dilution of immediate returns, including enhancing core business operations and improving fund management [9][11]. - Commitments from major stakeholders, including the controlling shareholder and management, have been made to ensure the effectiveness of these measures and to protect shareholder interests [12][13].
东山精密: 关于调整向特定对象发行股票发行价格和发行数量的公告
Zheng Quan Zhi Xing· 2025-05-27 08:11
Core Points - The company has completed the implementation of its stock issuance plan, adjusting the price from 11.24 CNY/share to 11.17 CNY/share and increasing the total number of shares to be issued from 124,911,031 shares to 125,693,822 shares [1][5] Group 1: Stock Issuance Details - The stock issuance plan has been approved by multiple board meetings and the annual general meeting, and has received regulatory approval from the Shenzhen Stock Exchange and the China Securities Regulatory Commission [1][2] - The adjusted issuance price of 11.17 CNY/share is based on the previous price of 11.24 CNY/share after accounting for a cash dividend of 0.07 CNY/share [4][5] - The total amount to be raised from this issuance is capped at 140,400 million CNY, with specific commitments from major shareholders for their respective subscription amounts [2][5] Group 2: Dividend Distribution - The company will distribute a cash dividend of 2.50 CNY per 10 shares, totaling approximately 118,795,180.63 CNY, with the record date set for May 26, 2025 [2][4] - The dividend distribution will not include stock dividends or capital reserve transfers, and adjustments will be made to the per-share distribution if there are changes in the total share capital before the record date [4]
每周股票复盘:华能水电(600025)2024年利润82.97亿元,2025年计划融资799.16亿元
Sou Hu Cai Jing· 2025-05-24 01:00
Core Viewpoint - Huaneng Lancang River Hydropower Co., Ltd. has shown positive financial performance in 2024, with plans for significant financing and bond issuance in 2025 [2][6]. Company Announcements - The company will hold its 2024 annual shareholders' meeting in May 2025 in Kunming, Yunnan, to discuss various proposals including financial reports and profit distribution [1]. - The company achieved a total revenue of 24.882 billion yuan and a net profit of 8.297 billion yuan in 2024, with total assets of 214.607 billion yuan and a debt-to-asset ratio of 63.11% [2]. - The company plans to donate 58.091 million yuan in 2025, an increase from 40.3441 million yuan in 2024 [2]. Financing and Debt Issuance - The company has completed the issuance of two bonds totaling 2 billion yuan, with interest rates of 1.60% and 1.72% [4][6]. - The company plans to raise 79.916 billion yuan in 2025, with capital expenditures projected at 25.735 billion yuan [2][6]. - The company has received an inquiry from the Shanghai Stock Exchange regarding its application for a specific stock issuance, which is pending approval [3][6].
中航沈飞: 中航沈飞股份有限公司2025年第一次临时股东大会会议资料
Zheng Quan Zhi Xing· 2025-05-23 09:16
Core Points - The company is holding its first extraordinary general meeting of shareholders in 2025 to discuss key proposals related to extending the validity period of stock issuance and amending the company's articles of association [1][4][5]. Group 1: Meeting Details - The meeting is scheduled to take place at the company's office in Shenyang, Liaoning Province, on May 28, 2025 [1]. - Shareholders must register for the meeting between 9:30 AM to 11:30 AM and 1:30 PM to 4:00 PM on the same day to confirm their attendance [1][2]. Group 2: Proposals - Proposal One aims to extend the validity period of the company's 2023 stock issuance resolution by an additional 12 months, due to the anticipated inability to complete all related work before the original authorization expires [4][5]. - Proposal Two involves amending the company's articles of association and related rules, including the cancellation of the supervisory board and adjustments to governance structures to enhance corporate governance [6][7]. Group 3: Voting Procedures - The voting at the meeting will be conducted by a named ballot, where each shareholder has one vote per share held [2][4]. - Shareholders are required to fill out the voting ballot accurately, indicating their agreement, disagreement, or abstention [2][4].
宏达股份向控股股东定增获上交所通过 中信证券建功
Zhong Guo Jing Ji Wang· 2025-05-23 02:16
Core Viewpoint - Hongda Co., Ltd. has received approval from the Shanghai Stock Exchange for its plan to issue shares to specific investors, pending final approval from the China Securities Regulatory Commission [1][2]. Group 1: Share Issuance Details - The total amount of funds to be raised through the issuance is 285,292.80 million RMB, which will be used for debt repayment and to supplement working capital [2]. - The shares will be issued at a price of 4.68 RMB per share, which is not less than 80% of the average trading price over the 20 trading days prior to the pricing date [3]. - A total of 609,600,000 shares will be issued, representing no more than 30% of the total share capital before the issuance [4]. Group 2: Shareholder and Control Information - The shares will be issued to Shudao Group, the controlling shareholder of the company, which constitutes a related party transaction as per the listing rules [4]. - The issuance will not change the control of the company, as Shudao Group will maintain its status as the controlling shareholder after the issuance [4]. Group 3: Regulatory and Advisory Information - The issuance is sponsored by CITIC Securities Co., Ltd., with Guo Hao and Li Yanping serving as the sponsoring representatives [5].
晶华新材: 上海晶华胶粘新材料股份有限公司2024年度以简易程序向特定对象发行A股股票上市公告书
Zheng Quan Zhi Xing· 2025-05-22 10:28
股票简称:晶华新材 股票代码:603683 上海晶华胶粘新材料股份有限公司 上市公告书 保荐人(主承销商) (上海市黄浦区中山南路 119 号东方证券大厦) 二〇二五年五月 特别提示 一、发行数量及价格 二、新增股票上市时间 新增股份将于限售期届满后的次一交易日起在上海证券交易所主板上市流 通交易,如遇法定节假日或休息日,则顺延至其后的第一个交易日。 三、新增股份的限售期安排 本次发行对象共 8 名,均以现金参与认购,本次发行对象认购的股份自发行 结束之日起六个月内不得转让,法律法规对限售期另有规定的,依其规定。发行 对象认购的本次发行的股票,因公司分配股票股利、资本公积转增股本等情形所 衍生取得的股票亦应遵守上述限售期的安排。限售期结束后按中国证监会及上海 证券交易所的有关规定执行。发行对象因本次交易取得的上市公司股份在限售期 届满后减持还需遵守《中华人民共和国公司法》《中华人民共和国证券法》《上 海证券交易所股票上市规则》等相关法律法规及规范性文件。 目 录 | | | 释 义 | | --- | --- | --- | | 在本上市公告书中,除非文意另有所指,下列词语具有如下含义: | | | | 晶华 ...
晶华新材: 晶华新材关于2024年度以简易程序向特定对象发行股票发行结果暨股本变动公告
Zheng Quan Zhi Xing· 2025-05-22 10:21
Summary of Key Points Core Viewpoint Shanghai Jinhua Adhesive New Materials Co., Ltd. has completed a simplified procedure for issuing shares to specific investors, resulting in an increase in total share capital and a change in the company's share structure. Group 1: Issuance Overview - The company issued 27,199,772 shares at a price of 8.36 RMB per share, raising a total of approximately 227.39 million RMB [5][6][7] - The total share capital increased from 262,499,289 shares to 289,699,061 shares following the issuance [2][13] - The newly issued shares are subject to a six-month lock-up period, during which they cannot be transferred [1][6] Group 2: Regulatory Compliance - The issuance process complied with relevant regulations and received approval from the China Securities Regulatory Commission (CSRC) [4][9] - The issuance was conducted in accordance with the company's internal decision-making procedures and received authorization from the shareholders' meeting [3][4] Group 3: Impact on Share Structure - The issuance did not result in any shareholder becoming a controlling shareholder, thus maintaining the company's control structure [2][15] - The proportion of limited circulation shares increased from 1.41% to 10.67% post-issuance, while unlimited circulation shares remained at 89.33% [15][16] Group 4: Financial Implications - The total assets and net assets of the company are expected to increase, enhancing the company's capital strength and improving its financial structure [16] - The funds raised will be used for projects aligned with national industrial policies and the company's strategic development plans, which are expected to expand production capacity [16] Group 5: Investor Information - The main investors in this issuance include Shanghai Fengchi Asset Management Co., Ltd. and Beijing Jintai Private Fund Management Co., Ltd., among others [10][12] - The issuance was conducted fairly and equitably, with no conflicts of interest involving major shareholders or management [9][12]
圣达生物: 浙江圣达生物药业股份有限公司第四届董事会第十七次会议决议公告
Zheng Quan Zhi Xing· 2025-05-22 10:16
第四届董事会第十七次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 证券代码:603079 证券简称:圣达生物 公告编号:2025-024 浙江圣达生物药业股份有限公司 为规范公司募集资金的使用与管理,保护投资者合法权益,根据《上市公 司监管指引第2号——上市公司募集资金管理和使用的监管要求》《上海证券交 易所股票上市规则(2025年4月修订)》等法律、法规、规范性文件以及《浙江 圣达生物药业股份有限公司募集资金管理办法》的有关规定,公司董事会同意 公司及子公司通辽市圣达生物工程有限公司依法依规在中国工商银行股份有限 公司天台支行、中国农业银行股份有限公司天台县支行、中国银行股份有限公 司天台县支行、中国建设银行股份有限公司天台支行、中国银行股份有限公司 开鲁支行开立募集资金专项账户,用于本次向特定对象发行股票募集资金的专 项存储和使用,并将按照规定与保荐人、存放募集资金的商业银行签署募集资 金监管协议,对募集资金的存放和使用情况进行监管。 董事会同意授权公司董事长及其授权人士全权办理募集 ...
盛美上海: 关于向特定对象发行A股股票预案及相关文件修订情况说明的公告
Zheng Quan Zhi Xing· 2025-05-21 12:09
证券代码:688082 证券简称:盛美上海 公告编号:2025-034 盛美半导体设备(上海)股份有限公司 关于向特定对象发行 A 股股票预案及相关文件 修订情况说明的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 盛美半导体设备(上海)股份有限公司(以下简称"公司")2024 年度向特 定对象发行 A 股股票相关议案已由第二届董事会第八次会议、2024 年第一次临 时股东大会、第二届董事会第十四次会议、第二届董事会第十六次会议、2025 年第一次临时股东大会审议通过。 公司根据最新情况,于 2025 年 5 月 20 日召开了第二届董事会第二十次会议, 审议通过了《关于公司 2024 年度向特定对象发行 A 股股票预案(二次修订稿) 的议案》 《关于公司 2024 年度向特定对象发行 A 股股票方案论证分析报告(二次 修订稿)的议案》 《关于公司 2024 年度向特定对象发行 A 股股票募集资金使用可 行性分析报告(二次修订稿)的议案》等相关议案。 本次拟对向特定对象发行股票预案及相关文件进行相应修订,除修订了本次 ...
博俊科技: 江苏博俊工业科技股份有限公司2024年度以简易程序向特定对象发行股票发行情况报告书
Zheng Quan Zhi Xing· 2025-05-20 13:59
江苏博俊工业科技股份有限公司 发行情况报告书 保荐人(主承销商) 二零二五年五月 发行人全体董事、监事、高级管理人员声明 本公司全体董事、监事、高级管理人员承诺本发行情况报告书不存在虚假记 载、误导性陈述或重大遗漏,并对其真实性、准确性、完整性承担相应的法律责 任。 全体董事签字: | 伍亚林 | | 伍丹丹 | 金秀铭 | | --- | --- | --- | --- | | 李文信 | | 张梓太 | 许述财 | | 高 | 芳 | | | 江苏博俊工业科技股份有限公司 | | | 发行人全体董事、监事、高级管理人员声明 本公司全体董事、监事、高级管理人员承诺本发行情况报告书不存在虚假记 载、误导性陈述或重大遗漏,并对其真实性、准确性、完整性承担相应的法律责 任。 全体董事签字: | 伍亚林 | | 伍丹丹 | 金秀铭 | | --- | --- | --- | --- | | 李文信 | | 张梓太 | 许述财 | | 高 | 芳 | | | 江苏博俊工业科技股份有限公司 | | | 发行人全体董事、监事、高级管理人员声明 本公司全体董事、监事、高级管理人员承诺本发行情况报告书不存在虚假记 载、误导性 ...